Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Arrhythmia

Clinical Trial Details

Overview

Research Study Summary

A clinical trial seeking patients for a research study for the treatment of Cardiac Arrest or Arrhythmia

Research Study Title

Phase IIB Study of Novel Quantitative Neurodiagnostic Technology in the Early Period After Cardiac Arrest

Purpose

The purpose of the study is to collect EEG's as close to the cardiac arrest as possible using a standard hospital EEG machine and an investigational EEG device to help determine the neurological status of the cardiac arrest patient and to help decide on possible treatment and chance of recovery. The investigational EEG machine will be simple to operate as well as easy to interpret for the clinician and the nurses. It is not to replace the electrophysiologist interpretation but to determine ealy on if further evaluation and treatment can help the patient.

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Lead Sponsor

Infinite Biomedical Technologies

Facility Type

N/A

Eligibility

Both Male and Female ages 18 Years and up

Inclusion Criteria:

Cardiac Arrest:

  • Patients 18 years and older:

  • with cardiac arrest in the hospital and successfully resuscitated, or

  • with cardiac arrest out of the hospital and successfully resuscitated

ICD patients:

  • Patients 18 years and older:

  • Who are undergoing elective procedure in the electrophysiology laboratory for placement of a cardiac defibrillator and who will most likely undergo induction of ventricular arrhythmia as part of the procedure

Exclusion Criteria:

Cardiac Arrest:

  1. Cardiac arrest and a known pre-existing cerebral pathology such as brain tumor, cerebral hemorrhage, encephalitis or immediately post-op neurosurgery.

  2. CNS infection

  3. Skull defects and scalp diseases that are not amenable to standard EEG testing

ICD patients:

  1. Known pre-existing cerebral pathology such as brain tumor, cerebral hemorrhage, encephalitis or immediately post-op neurosurgery.

  2. CNS infection

  3. Skull defects and scalp diseases that are not amenable to standard EEG testing

Site Locations (3)

Country State City Zip Facility and Contact
United States Maryland Baltimore 21187 Johns Hopkins Hospital
Daniel F Hanley, MD
410-614-6996
dhanley@jhmi.edu

Romergryko Geocadin, MD
Principal Investigator
United States Maryland Baltimore 21224 Johns Hopkins Bayview Medical Center

Romergryko Geocadin, MD
Principal Investigator
United States Wisconsin Milwaukee 53226 Medical College of Wisconsin at Froedtert Memorial Luthern Hospital Clinics - Neurology
Michel Torbey, MD,MPH
414-805-5343
mtorbey@mcw.edu

Michel Torbey, MD, MPH
Principal Investigator

Contact

Romergryko Geocadin, MD
410-614-6145

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT00483873

Date Last Changed: January 28, 2009

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.